Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / GENOMIC REV ETF
-
Total 13F shares
-
19,742,778
-
Share change
-
-3,640,963
-
Total reported value
-
$624,094,591
-
Put/Call ratio
-
89%
-
Price per share
-
$31.49
-
Number of holders
-
307
-
Value change
-
-$149,933,659
-
Number of buys
-
92
-
Number of sells
-
208
Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q2 2022
As of 30 Jun 2022,
ARK ETF TR - GENOMIC REV ETF (ARKG) was held by
307 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,742,778 shares.
The largest 10 holders included
MORGAN STANLEY, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, LPL Financial LLC, UBS Group AG, Avidity Partners Management LP, GOLDMAN SACHS GROUP INC, BNP PARIBAS ARBITRAGE, SA, COMMONWEALTH EQUITY SERVICES, LLC, and STATE OF WISCONSIN INVESTMENT BOARD.
This page lists
311
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.